Kidney Allograft Fibrosis

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2018-04-04
Clinical Trial Update: Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis
An update on a clinical trial investigating urinary transglutaminase 2 as a biomarker for kidney allograft fibrosis. The study involves kidn…